192 related articles for article (PubMed ID: 24550423)
1. Prognostic impact of minimal pleural effusion in non-small-cell lung cancer.
Ryu JS; Ryu HJ; Lee SN; Memon A; Lee SK; Nam HS; Kim HJ; Lee KH; Cho JH; Hwang SS
J Clin Oncol; 2014 Mar; 32(9):960-7. PubMed ID: 24550423
[TBL] [Abstract][Full Text] [Related]
2. Minimal Pleural Effusion in Small Cell Lung Cancer: Proportion, Mechanisms, and Prognostic Effect.
Ryu JS; Lim JH; Lee JM; Kim WC; Lee KH; Memon A; Lee SK; Yi BR; Kim HJ; Hwang SS
Radiology; 2016 Feb; 278(2):593-600. PubMed ID: 26323029
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
4. The role of CT pulmonary angiography in the investigation of unilateral pleural effusions.
Hooper C; Laurence I; Harvey J; Morley A; Darby M; Edey A; Maskell N
Respiration; 2014; 87(1):26-31. PubMed ID: 23816819
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of Prognostic Factors and Clinical Characteristics for Patients with Limited Stage Small Cell Lung Cancer with Pleural Effusion].
Xu K; Wang Y; Qi J; Zhao L; Wang P
Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):16-23. PubMed ID: 29357968
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology.
Nakao M; Hoshi R; Ishikawa Y; Matsuura Y; Uehara H; Mun M; Nakagawa K; Okumura S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):777-82. PubMed ID: 25762707
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.
Lim JU; Yeo CD; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Lee SH
PLoS One; 2018; 13(7):e0200341. PubMed ID: 30005083
[TBL] [Abstract][Full Text] [Related]
8. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion.
Duysinx B; Corhay JL; Larock MP; Nguyen D; Bury T; Hustinx R; Louis R
Nucl Med Commun; 2008 Nov; 29(11):982-6. PubMed ID: 18836376
[TBL] [Abstract][Full Text] [Related]
11. Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trial.
Yamaguchi M; Ichinose Y; Shimamatsu S; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Seto T; Takenoyama M
Surg Oncol; 2015 Jun; 24(2):78-83. PubMed ID: 25818753
[TBL] [Abstract][Full Text] [Related]
12. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of Minimal Pericardial Effusion in Patients With Advanced Non-small-cell Lung Cancer.
Kato R; Hayashi H; Chiba Y; Tanaka K; Takeda M; Nakagawa K
Clin Lung Cancer; 2017 Nov; 18(6):e449-e455. PubMed ID: 28576595
[TBL] [Abstract][Full Text] [Related]
14. Important prognostic factors for survival in patients with malignant pleural effusion.
Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
[TBL] [Abstract][Full Text] [Related]
15. Pleural effusion-based nomogram to predict outcomes in unselected patients with multiple myeloma: a large single center experience.
Hou ZL; Kang Y; Yang GZ; Wang Z; Wang F; Yu YX; Chen WM; Shi HZ
Ann Hematol; 2021 Jul; 100(7):1789-1801. PubMed ID: 33715037
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
[TBL] [Abstract][Full Text] [Related]
17. Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Hsu IL; Su WC; Yan JJ; Chang JM; Lai WW
Lung Cancer; 2009 Sep; 65(3):371-6. PubMed ID: 19157636
[TBL] [Abstract][Full Text] [Related]
18. Pleural effusion as a significant prognostic factor in non-small cell lung cancer.
Naito T; Satoh H; Ishikawa H; Yamashita YT; Kamma H; Takahashi H; Ohtsuka M; Hasegawa S
Anticancer Res; 1997; 17(6D):4743-6. PubMed ID: 9494600
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
[TBL] [Abstract][Full Text] [Related]
20. Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination.
Kimura M; Tojo T; Naito H; Nagata Y; Kawai N; Taniguchi S
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):568-71. PubMed ID: 20093263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]